Adaptive Biotechnologies (ADPT) Misses Q2 EPS by 11c
Tweet
Share
E-mailGet Alerts ADPT Hot Sheet
Price: $28.61 +0.21%
EPS Growth %: -266.7%
Financial Fact:
Selling, marketing and administrative: 9.3M
Today's EPS Names:
VIVO, OCCI, ALZN, More
EPS Growth %: -266.7%
Financial Fact:
Selling, marketing and administrative: 9.3M
Today's EPS Names:
VIVO, OCCI, ALZN, More
Join SI Premium – FREE
Adaptive Biotechnologies (NASDAQ: ADPT) reported Q2 EPS of ($0.25), $0.11 worse than the analyst estimate of ($0.14). Revenue for the quarter came in at $71.55 million versus the consensus estimate of $65.75 million.
For earnings history and earnings-related data on Adaptive Biotechnologies (ADPT) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- U.S. and Denmark close in on a Greenland deal - Reuters
- Trump says U.S. and Denmark reached permanent security deal over Greenland
- Leidos wins $85m Air Force contract for aerospace design
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
